Skip to content

ECT decision support tool

Shared decision making about ECT supported by AI - ECT decision support tool

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58489
Enrollment
50
Registered
2025-10-22
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder, bipolar disorder, schizoaffective disorder Depressive episodes

Interventions

During the consultation in which ECT is discussed as a potential treatment option, the clinician will use the ECT decision support tool as addition to standard care. The tool automatically retrieves r
it is a support tool, and the clinician remains responsible. This intervention is non-invasive and carries no physical burden. The tool will be used for every patient that participates in the study. T

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients aged =18 years Patients diagnosed with a major depressive episode and an indication for ECT  Patient is able to provide informed consent 

Exclusion criteria

Exclusion criteria: Incapacity of will 

Design outcomes

Primary

MeasureTime frame
Our primary outcome is how the ECT decision support tool is experienced by both patients and clinicians in terms of usability and satisfaction during routine consultations with regards to the shared-decision making process. Usability will be measured with the HSUS. Satisfaction is assessed through a short self-developed questionnaire consisting of five questions. Additionally, a standardized observation form will be filled out by the researchers during the consultations which provides additional qualitative data to assess usability and satisfaction. Moreover, qualitative data on the overall experience of patients with the ECT decision support tool, is gathered during the focus group.

Secondary

MeasureTime frame
Our secondary outcomes focus on exploring potential safety risks associated with the use of the ECT decision support tool during routine clinical consultations and to identify suggestions for improvements of the ECT decision support tool. Qualitative data on safety will be gathered through the observation forms during the routine consultations. It will be observed how often and to what extent certain risks occur and how they are mitigated.We will also evaluate remission rates, based on Hamilton Depression Rating Scale (HDRS) scores (HDRS = 7 at the end of the ECT course).

Countries

Netherlands

Contacts

Public ContactK Hagoort

Universitair Medisch Centrum Utrecht

k.hagoort@umcutrecht.nl0648463649

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026